<DOC>
	<DOCNO>NCT00179881</DOCNO>
	<brief_summary>Treatment study combine two drug : Thalomid™ ( thalidomide ) carboplatin . Thalidomide available many year use treat many different illness . Carboplatin effective medicine kill cancer cell . Thalidomide work block angiogenesis ( process new blood vessel formation ) . If tumor blood vessel provide oxygen nutrient , able grow . This research look combine effect thalidomide ( prevent tumor growth ) tumor kill effect carboplatin effect long-term outlook patient tumor . This study try find well Thalomid™ carboplatin combine radiation therapy work treat child newly diagnose brain stem glioma . This study look well Thalomid ™ carboplatin work patient recurrent brain stem glioma . This study also look side effect treatment .</brief_summary>
	<brief_title>Thalomid Carboplatin Treatment Pediatric Brain Stem Glioma</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Brain Stem Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Patients must &gt; /= 3 &lt; /= 21 year age . Patients must newly diagnose progressive brain stem tumor . If biopsy perform , patient high low grade astrocytomas eligible . Nonhistologically confirm brain stem tumor eligible . Neuroradiographic confirmation brain stem glioma mandatory study entry . Cervicomedullary junction tumor ineligible . Patients diagnosis NF1 ineligible . Patients must register within 6 week diagnosis recurrence . Patients must life expectancy &gt; 6 week . Patients must adequate hematologic renal function : ANC &gt; 1,000/ul , platelet &gt; 100,000/ul creatinine normal age : &lt; /= 0.7 mg/dl ( age 310yrs . ) , &lt; /= 1.0 mg/dl ( 1112yrs. ) . &lt; /= 1.2 ( 1321yrs. ) . Written informed consent must obtain accord institutional guideline . Pregnant nursing woman ineligible . Patients must register within 3 day prior start protocol treatment . Patients must start treatment informed consent give patient register . Willingness ability comply FDAmandated S.T.E.P.S.® program .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Brain stem glioma</keyword>
</DOC>